That is great news and another blue sky opportunity for Atomo in the future.
I spoke with John Kelly at the Microcaps conference last month and he mentioned they will be commissioned by Nexsen to develop the technology.
They must like what they see so far to also commit to manufacturing for pivotal clinical trials.
Nexsen have received $5.5M in grant funding so far.
AT1 FY21 - General Discussion + FA, page-2433
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $1.169K | 58.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1629606 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 152000 | 2 |
View Market Depth
| Last trade - 14.19pm 09/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |